PDZK1IP1 and pancreatic neoplasm: To explore the effect of MAP17 on the response to these drugs in vitro, we determined the drug concentration that leads to 50% cell growth inhibition (IC50) in both pancreatic tumor cell lines (PANC-1 and HPAF-II) and correlated these data with MAP17 levels (Table 1).